Concepedia

Tomokazu Nagano

TN

12

Publications

839

Citations

12

H-Index

1989

Active since

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

National Institutes of Health

National Cancer Institute

Center for Cancer Research

Tomokazu Nagano is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, cell biology, and pathology.

Top concepts

Publications per year

1989–2021

12

Publications

12

Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy

Ryuichi Morishita, Shigefumi Nakamura, Shinichiro Hayashi et al. · Hypertension · 1999 · 270 citations

, , +19

The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARα

Qian Yang, Tomokazu Nagano, Yatrik M. Shah et al. · Toxicological Sciences · 2007 · 171 citations · Full text

Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease : Downregulation of HGF in Response to Hypoxia in Vascular Cells

S. Hayashi, R. Morishita, Shinichiro Nakamura et al. · Circulation · 1999 · 130 citations

, , +22

Binding Specificity ofLactobacillusto Glycolipids

Kenji Yamamoto, Takuya Miwa, Hiromu Taniguchi et al. · Biochemical and Biophysical Research Communications · 1996 · 54 citations

, , +3

Lysosomal SLC46A3 modulates hepatic cytosolic copper homeostasis

Jung-Hwan Kim, Tsutomu Matsubara, Jaekwon Lee et al. · Nature Communications · 2021 · 49 citations · Full text

Rows per page

1–5 of 12